MMP3 Is a Non-invasive Biomarker of Rejection in Skin-Bearing Vascularized Composite Allotransplantation: A Multicenter Validation Study

Background: There is unmet need for non-invasive immunomonitoring to improve diagnosis and treatment of acute rejection in vascularized composite allotransplantation (VCA). Circulating matrix metalloproteinase 3 (MMP3) was described as a candidate non-invasive biomarker to predict treatment response...

Descripción completa

Detalles Bibliográficos
Autores principales: Kollar, Branislav, Uffing, Audrey, Borges, Thiago J., Shubin, Andrey V., Aoyama, Bruno T., Dagot, Céline, Haug, Valentin, Kauke, Martin, Safi, Ali-Farid, Talbot, Simon G., Morelon, Emmanuel, Dakpe, Stéphanie, Pomahac, Bohdan, Riella, Leonardo V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897344/
https://www.ncbi.nlm.nih.gov/pubmed/31849957
http://dx.doi.org/10.3389/fimmu.2019.02771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897344/
https://www.ncbi.nlm.nih.gov/pubmed/31849957
http://dx.doi.org/10.3389/fimmu.2019.02771

Ejemplares similares